Evidence map›Paper›PMID 39449002›Full record

ArticleTrials2024

Supporting African communities to increase resilience and mental health of kids with developmental disabilities and their caregivers using the World Health Organization's Caregiver Skills Training Programme (SPARK trial): study protocol for a cluster randomised clinical controlled trial.

Melissa Washington-Nortey, Vibian Angwenyi, Mekdes Demissie, Eva Mwangome, Tigist Eshetu, Hanna Negussie, Kimberley Goldsmith, Andrew Healey, Merga Feyasa, Girmay Medhin and 23 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Melissa Washington-NorteyDepartment of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK.
Vibian AngwenyiInstitute for Human Development, Aga Khan University, P.O. Box 30270-00100, Nairobi, Kenya.
Mekdes DemissieCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Eva MwangomeNeuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya.
Tigist EshetuCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Hanna NegussieCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Kimberley GoldsmithDepartment of Biostatistics and Health Informatics, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK.
Andrew HealeyHealth Service and Population Research, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK.
Merga FeyasaCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Girmay MedhinCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Amanuel BelayCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Temesgen AzmerawCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Medhanit GetachewCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Rahel BirhaneCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Carophine NasambuNeuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya.
Tsegereda Haile KifleDepartment of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK.
Angela KairuNeuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya.
Beatrice MkubwaInstitute for Human Development, Aga Khan University, P.O. Box 30270-00100, Nairobi, Kenya.
Fikirte GirmaCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Rehana AbdurahmanYekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
Ruth TsigebrhanCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Liya TesfayeNia Foundation, Joy Center for Autism, Addis Ababa, Ethiopia.
Leonard MbonaniKuhenza for Children's Foundation, Kilifi, Kenya.
Nadine SewardSchool of Health and Social Science, University of Edinburgh, Edinburgh, UK.
Tony CharmanDepartment of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK.
Andrew PicklesDepartment of Biostatistics and Health Informatics, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK.
Erica SalomoneUniversity of Milano-Bicocca, Milan, Italy.
Chiara ServiliDepartment of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Edwine BarasaNeuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya.
Charles R NewtonNeuroscience Group KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), P.O. Box 230-80108, Kilifi, Kenya.
Charlotte HanlonCentre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Amina Abubakar *Institute for Human Development, Aga Khan University, P.O. Box 30270-00100, Nairobi, Kenya.
Rosa A Hoekstra *Department of Psychology, Institute of Psychology, Psychiatry and Neuroscience (IoPPN), King's College London, London, UK. rosa.hoekstra@kcl.ac.uk.ORCID http://orcid.org/0000-0002-1333-9762

Funding

National Institute for Health and Care Research NIHR200842World Health Organization 001
6 · The paper itself

Abstract

backgroundMost children with developmental disabilities (DD) live in low- and middle-income countries, but access to services is limited, impacting their ability to thrive. Pilot study findings of the World Health Organization's Caregiver Skills Training (WHO CST) intervention, which equips caregivers with strategies to facilitate learning and adaptive behaviours in children with DD, are promising but evidence from an appropriately powered trial delivered by non-specialist facilitators is lacking. This study will investigate the effectiveness and the resource impacts and costs and consequences of the WHO CST intervention in four sites in rural and urban Kenya and Ethiopia.

methodsThis is a 2-arm multi-site hybrid type-1 effectiveness implementation cluster randomised controlled superiority trial. After baseline assessments (T0) are completed by participants in clusters comprising 7 to 10 caregiver-child dyads, the clusters will be randomised to either the WHO CST intervention arm or a waitlist enhanced care as usual control arm. Further assessments will be completed at endpoint (T1, 18 ± 2 weeks after randomisation) and follow-up (T2, 44 ± 2 weeks after randomisation). The intervention comprises three individualised home visits and nine group sessions with trained non-specialist facilitators. Participants in the control arm will receive the intervention after completing follow-up assessments. We aim to recruit 544 child-caregiver dyads, evenly distributed across the two arms and countries. The co-primary outcomes are the child-focused Child Behavior Checklist (assessing emotional and behavioural problems) and the caregiver-focused Pediatric Quality of Life Inventory (assessing caregiver quality of life), both assessed at endpoint. Secondary outcome measures comprise the two co-primary outcomes at follow-up and ten additional outcome measures at endpoint, assessing stigma-based experiences, depressive symptoms, household food insecurity, child disciplinary strategies and beliefs, CST knowledge and skill competencies, caregiver and child quality of life, social support, and children's communication modes and functions. After quantitative follow-up assessments are completed, a mixed-methods evaluation approach will be used to investigate implementation processes and acceptability, feasibility, and potential sustainability of the intervention. DISCUSSION: The study's findings will provide evidence of the effectiveness and resource impacts and costs and consequences of a non-specialist-delivered intervention in under-resourced contexts in one low-income and one middle-income country in East Africa. Findings will inform future research, intervention, and policy efforts to support children with DD and their families in under-resourced majority world contexts.

trial registrationPan African Clinical Trial Registry PACTR202310908063134. Registered on October 16, 2023.

Indexed as

CaregiversDevelopmental DisabilitiesMental HealthResilience, PsychologicalAdaptation, PsychologicalChildChild BehaviorChild DevelopmentChild, PreschoolEquivalence Trials as TopicEthiopiaFemaleHumansKenyaMaleMulticenter Studies as TopicCaregiversCaregiver Skills TrainingChildrenCluster randomised controlled trialDevelopmental disabilitiesEthiopiaKenyaMental healthWorld Health Organization

Identifiers

PMID39449002
PMCPMC11515546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.